Grand River Aseptic Manufacturing (GRAM), a sterile injectable contract manufacturer of biologics, small molecules, and vaccines, has completed its finishing and warehouse center expansion. The expansion added 90,000-square-feet to the existing 110,000-square-feet, totaling 200,000-square-feet of inspection, packaging, testing, and warehouse capabilities.

GRAM’s expansion of additional capabilities and systems supports an industry-wide need for syringe, cartridge, and vial filling and finishing, as well as the growth in advanced drug delivery systems.

“The increase in capabilities, capacity, and redundancy from this expansion sustains GRAM’s commitment to delivering quality products and supporting our partners with contract manufacturing that aligns with their needs,” said Tom Ross, president and CEO of Grand River Aseptic Manufacturing. “GRAM’s authenticity and transparency with our partners and component manufacturers allow us to serve with intention and continue our growth. I look forward to welcoming new and current customers to see all we offer.”

The 200,000-square-foot finishing and warehouse center will incorporate:

• Four fully automated inspection systems (Korber and Optrel), eight semi-automated (Dabrico), and twelve manual inspection booths.
• Four labeling and packing lines (Dividella, Uhlmann, Bausch + Ströbel, Marchesini) with future label and pack space.
• Two autoclaves for product terminal sterilization.
• QC analytical and sterility lab with sterility isolators (SKAN) to support lyophilized, biologics, and small molecule product testing.
• Three -50°C walk-in freezers and three walk-in finished product (2-8°C and -20°C) refrigerated frozen units.
• 30,000-square-feet reserved for additional syringe/cartridge filling lines.
• Over 50,000-square-feet of material and finished product storage.

Grand River Aseptic Manufacturing’s finishing and warehouse center compliments its recently expanded filling facility, which includes four Bausch + Ströbel filling lines with SKAN isolator technology to manufacture clinical and commercial scale liquid vials, lyophilized vials, syringes, and cartridges. GRAM has over 100 million units of capacity to support the pharma and biotech industries.